Plant Variety Rights

(PVRs)

Experts in IP Protection for Plant Variety Inventions


Improvement of crop and ornamental species by genetic modification or modern breeding techniques remains a significant area of innovation. A number of IP rights may be suitable for protecting plant inventions, including patents, trade marks, plant Variety Rights (PVRs) and entry on the national list or common catalogue. Our experienced IP specialists are well placed to assist our clients in this area, having a wealth of practical experience.

In Europe, individual plant varieties that are distinct, uniform and stable can be protected either nationally or at European Community level. Separately, European and national patents can be obtained for plants and plant-related inventions which are not restricted to plant varieties per se, although certain plant breeding methods and plants obtained by those methods are excluded from patentability.  Despite the EU’s strict policies on growing genetically modified crops and uncertainty surrounding the use of genetic resources in plant breeding, there is considerable commercial interest in these technical areas and in IP protection for the output of biotech research and classical breeding programs.

Our expert IP team is led by Frances Salisbury, who has a PhD in plant molecular genetics. An expert in this field Frances has completed the official World Intellectual Property Organisation (WIPO) course on Plant Variety Protection under the UPOV Convention.

Read our Plant Variety Rights Law and Practice guide.

Read our blogs

Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024

Mewburn Ellis is proud to have worked on 24 of the 100 top-selling pharmaceuticals of 2024

by Adam Gregory

Mewburn Ellis works with some of the world’s most important pharmaceuticals and biologics across a broad range of therapeutic areas.

Optimising Training for the Menstrual Cycle

Optimising Training for the Menstrual Cycle

by Sarah Harvey

In recent years, there's been a noticeable shift in how we approach female athletic performance, with increasing attention paid to the menstrual cycle and its impact on training outcomes. No longer a ...

Mewburn Ellis Extends BII Residency, Deepening Support for Denmark’s Innovation Ecosystem

Mewburn Ellis Extends BII Residency, Deepening Support for Denmark’s Innovation Ecosystem

by Eliot Ward

Mewburn Ellis is pleased to announce that we have extended our residency at the BioInnovation Institute (BII) in Copenhagen for another two years — a decision that reinforces our long-standing ...

Most opposed patents of 2024

Most opposed patents of 2024

by Katherine Green

The list is, again, dominated by patents for therapeutic treatments, although the trends seen last year for patents on recycling and renewable technologies have continued (these are the green bars in ...

BluMaiden: Pioneering AI-Driven Precision in Immunotherapy Response Prediction

BluMaiden: Pioneering AI-Driven Precision in Immunotherapy Response Prediction

by Eliot Ward

BluMaiden uses AI and microbiome insights to boost immunotherapy prediction and speed up drug discovery.

Combatting AMR in UTIs

Combatting AMR in UTIs

by Sarah Harvey

Urinary tract infections (UTIs) are among the most common bacterial infections, affecting millions of people worldwide. The term ‘UTIs’ encompasses infections in any part of the urinary system (the ...

Forward Magazines 4

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.